Innate Pharma

是其中之一......

• CAC All-Trade.

Innate Pharma 是一家在股票代码 IPH (FR) 下上市的公司。

查看带有其 19 名主要高管的组织结构图

Innate Pharma 搜索最多的简介

• Herve Brailly, Interim Chief Executive Officer
• Irina Staatz-Granzer, Chairman of the Board
• Gilles Brisson, Member of the Supervisory Board

高管在Innate Pharma变化

• Arvind Sood已作为Executive Vice President and President of US Operations加入公司  (新闻发布的2024一月4号).
• Yannis Morel 曾任 Executive Vice President, Product Portfolio Strategy & Business Development and Member of the Executive Board, 现升职为 Executive Vice President and Chief Operating Officer  (新闻发布的2024一月4号).
• Irina Staatz-Granzer 曾任 Vice-Chairman of the Supervisory Board, 现升职为 Chairman of the Board  (新闻发布的2023十二月19号).

更多的变化在％s

创建提醒
跟踪 Innate Pharma 的高管变动

Innate Pharma 拥有 1,863 家竞争者，其中包括 Pfizer (美国(美洲))、Sanofi (法国) 和 Johnson & Johnson (美国(美洲))。

Popular M&A news in 药店

• AstraZeneca has announced the acquisition of Fusion Pharma  (公布2024三月23号).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (公布2024三月19号).
• Frontier Medicines 刚刚宣布为 80 筹款数百万美元。 (公布2024二月27号).

药店 行业的其他推荐联系人

• Ferring Pharmaceuticals 企业 Jean-Frédéric Paulsen - Executive Chairman of the Board
• Dirk Rossmann 企业 Alice Schardt-Rossmann - Managing Director
• Amolyt Pharma 企业 Thierry Abribat - Chief Executive Officer

了解更多有关药店行业的信息 >

Innate Pharma 的最新新闻稿

• Innate Pharma announces advancement of Sanofi-developed NK Cell Engager SAR443579/IPH6101 progressing to Phase 2 for blood cancer patients | Innate Pharma
• Innate Pharma to hold its Annual General Meeting of shareholders on May 23, 2024 | Innate Pharma
• Innate Pharma announces its participation in upcoming Investor Conference | Innate Pharma
• Innate Pharma files its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F | Innate Pharma
• Innate Pharma presents at AACR 2024 preclinical efficacy of its pre-IND drug candidate IPH45, a novel Nectin-4 Antibody Drug Conjugate | Innate Pharma
• All press releases | Innate Pharma
• Innate Pharma reports Full Year 2023 financial results and business update | Innate Pharma
• Innate Pharma announces its participation to upcoming investor conference | Innate Pharma
• Innate Pharma announces conference call and webcast for Full Year 2023 financial results | Innate Pharma
• Innate Pharma to present Nectin-4 Antibody Drug Conjugate IPH45 preclinical data at AACR 2024 | Innate Pharma
• View more press releases Close

关于 Innate Pharma 的社交媒体

• Innate Pharma 在 维基百科、谷歌新闻 和 雅虎财经
• Innate Pharma 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Herve Brailly

致电Innate Pharma，电话：+33 43...

查看组织结构图

Register to receive your alert

报告错误